PDS Biotechnology is a clinical stage immuno-oncology company with a growing pipeline of clinical-stage immunotherapies to treat various HPV-associated cancers, including head and neck cancer, cervical and anal cancers.
2025/7/6 11:27:30
(PDSB:NASDAQ)
Analyst coverage
Streetwise Reports Articles